T80.A11 Non-ABO incompatibility with delayed hemolytic transfusion reaction

Name of the Condition

• Non-ABO incompatibility with delayed hemolytic transfusion reaction.

Summary

This condition describes a delayed hemolytic transfusion reaction resulting from non-ABO blood group incompatibility. It occurs when the recipient’s immune system reacts to non-ABO antigens in transfused blood or blood products, leading to hemolysis that typically manifests days to weeks after the transfusion. The reaction is characterized by immune-mediated destruction of transfused red blood cells, which can cause clinical symptoms and laboratory abnormalities.

Causes

Delayed hemolytic transfusion reactions due to non-ABO incompatibility are caused by antibodies in the recipient that target minor blood group antigens (e.g., Rh, Kell, Duffy, Kidd) present in the donor blood. These antibodies may develop from prior sensitization through pregnancy, previous transfusions, or organ transplants. The reaction is triggered when incompatible blood is transfused, leading to delayed immune activation and red blood cell lysis.

Risk Factors

• Prior exposure to non-ABO antigens (e.g., through pregnancy or previous transfusions)
• History of multiple transfusions
• Underlying immune-mediated conditions
• Use of blood products with non-ABO antigen mismatches
• Lack of pre-transfusion antibody screening in high-risk patients

Symptoms

• Fever, chills, or rigors
• Jaundice or dark urine
• Fatigue or malaise
• Unexplained anemia
• Elevated bilirubin or LDH levels

Diagnosis

Diagnosis involves correlating clinical symptoms with laboratory findings, including a positive direct antiglobulin test (DAT), identification of non-ABO antibodies, and evidence of hemolysis (e.g., elevated bilirubin, LDH, or reticulocytosis). A review of transfusion history and antibody screening results is essential to confirm the reaction.

Treatment Options

Management focuses on supportive care, including monitoring for hemolysis and anemia. Transfusion of compatible blood products may be necessary if anemia is severe. Corticosteroids or other immunosuppressants are rarely used but may be considered in severe cases. Addressing the underlying cause, such as discontinuing the offending transfusion, is critical.

Prognosis and Follow-Up

Most delayed hemolytic transfusion reactions are mild and resolve with supportive care. However, severe cases may require intervention. Follow-up includes monitoring hemoglobin levels, bilirubin, and antibody status to ensure resolution and prevent future reactions.

Complications

• Severe anemia requiring transfusion
• Acute kidney injury (rare)
• Transfusion-related acute lung injury (TRALI) (rare)
• Prolonged jaundice or hyperbilirubinemia

Lifestyle & Prevention

• Ensure accurate blood typing and crossmatching before transfusion.
• Use leukoreduced blood products when appropriate.
• Screen for non-ABO antibodies in high-risk patients (e.g., those with prior transfusions or pregnancies).
• Educate patients on reporting delayed symptoms after transfusion.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, jaundice, dark urine, or severe fatigue occur after a transfusion, especially if they develop days to weeks later.

Tips for Medical Coders

Code T80.A11 is used for delayed hemolytic transfusion reactions due to non-ABO incompatibility. Documentation should specify the reaction as "delayed" and confirm non-ABO antigen involvement. Include details such as antibody identification, timing of symptoms, and laboratory evidence of hemolysis to support the code.